Imaging Myofibrillar Disarray and Microvascular Dysfunction in Hypertrophic Cardiomyopathy: Novel Imaging Biomarkers for a New Era in Therapeutics
Circulation
.
2023 Sep 5;148(10):819-821.
doi: 10.1161/CIRCULATIONAHA.123.065789.
Epub 2023 Sep 5.
Authors
Michael P Ayers
1
,
Christopher M Kramer
1
2
Affiliations
1
From the Cardiovascular Division, Department of Medicine (M.P.A., C.M.K.), University of Virginia Health System, Charlottesville.
2
Department of Radiology and Medical Imaging (C.M.K.), University of Virginia Health System, Charlottesville.
PMID:
37669360
PMCID:
PMC10491427
DOI:
10.1161/CIRCULATIONAHA.123.065789
No abstract available
Keywords:
Editorials; cardiomyopathy, hypertrophic.
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biomarkers
Cardiomyopathy, Hypertrophic*
Humans
Mutation
Phenotype
Sarcomeres*
Substances
Biomarkers
Grants and funding
U01 HL117006/HL/NHLBI NIH HHS/United States